{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:08:39Z","timestamp":1792069719990,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"crossref","award":["705290"],"award-info":[{"award-number":["705290"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["153132"],"award-info":[{"award-number":["153132"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13346-019-00674-7","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:04:27Z","timestamp":1567537467000},"page":"202-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9462-6324","authenticated-orcid":false,"given":"Kent T. J.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malathi","family":"Anantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada W. Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayesh A.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gardenia G. C.","family":"Militao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Wehbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter R.","family":"Cullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel B.","family":"Bally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"issue":"1","key":"674_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/j.gastro.2011.05.020","volume":"141","author":"JE Lee","year":"2011","unstructured":"Lee JE, Chan AT. Fruit, vegetables, and folate: cultivating the evidence for cancer prevention. Gastroenterology. 2011;141(1):16\u201320. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2011.05.020\n\n.","journal-title":"Gastroenterology."},{"issue":"6","key":"674_CR2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/febs.13206","volume":"282","author":"Z Yang","year":"2015","unstructured":"Yang Z, Liu Y, Liao J, Gong C, Sun C, Zhou X, et al. Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling. FEBS J. 2015;282(6):1111\u201325. \nhttps:\/\/doi.org\/10.1111\/febs.13206\n\n.","journal-title":"FEBS J"},{"issue":"5","key":"674_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/carcin\/bgh052","volume":"25","author":"TTT Nguyen","year":"2004","unstructured":"Nguyen TTT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004;25(5):647\u201359. \nhttps:\/\/doi.org\/10.1093\/carcin\/bgh052\n\n.","journal-title":"Carcinogenesis."},{"issue":"1","key":"674_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11130-010-0154-8","volume":"65","author":"R Mikstacka","year":"2010","unstructured":"Mikstacka R, Rimando A, Ignatowicz E. Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro. Plant Foods Hum Nutr. 2010;65(1):57\u201363. \nhttps:\/\/doi.org\/10.1007\/s11130-010-0154-8\n\n.","journal-title":"Plant Foods Hum Nutr"},{"issue":"10","key":"674_CR5","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1248\/bpb.26.1398","volume":"26","author":"MF Molina","year":"2003","unstructured":"Molina MF, Sanchez-Reus I, Iglesias I, Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharm Bull. 2003;26(10):1398\u2013402. \nhttps:\/\/doi.org\/10.1248\/bpb.26.1398\n\n.","journal-title":"Biol Pharm Bull"},{"key":"674_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jphotobiol.2012.05.020","volume":"114","author":"H-M Yang","year":"2012","unstructured":"Yang H-M, Ham Y-M, Yoon W-J, Roh SW, Jeon Y-J, Oda T, et al. Quercitrin protects against ultraviolet B-induced cell death in vitro and in an in vivo zebrafish model. J Photochem Photobiol B Biol. 2012;114:126\u201331. \nhttps:\/\/doi.org\/10.1016\/j.jphotobiol.2012.05.020\n\n.","journal-title":"J Photochem Photobiol B Biol"},{"issue":"11","key":"674_CR7","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1093\/jn\/136.11.2715","volume":"136","author":"A Belen Granado-Serrano","year":"2006","unstructured":"Belen Granado-Serrano A, Angeles Martin M, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase\/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr. 2006;136(11):2715\u201321.","journal-title":"J Nutr"},{"key":"674_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuint.2014.12.001","volume":"80","author":"H-C Pan","year":"2015","unstructured":"Pan H-C, Jiang Q, Yu Y, Mei J-P, Cui Y-K, Zhao W-J. Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells. Neurochem Int. 2015;80:60\u201371. \nhttps:\/\/doi.org\/10.1016\/j.neuint.2014.12.001\n\n.","journal-title":"Neurochem Int"},{"key":"674_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1177\/0960327114567766","volume":"34","author":"S Lee","year":"2015","unstructured":"Lee S, Oh K, Chung A, Park H, Lee S, Kwon S, et al. Protective role of quercetin against cisplatin-induced hair cell damage in zebrafish embryos. Hum Exp Toxicol. 2015;34:1043\u201352. \nhttps:\/\/doi.org\/10.1177\/0960327114567766\n\n.","journal-title":"Hum Exp Toxicol"},{"issue":"6","key":"674_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ajps.2014.05.005","volume":"9","author":"P Khadka","year":"2014","unstructured":"Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, et al. Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci. 2014;9(6):304\u201316. \nhttps:\/\/doi.org\/10.1016\/j.ajps.2014.05.005\n\n.","journal-title":"Asian J Pharm Sci"},{"issue":"9","key":"674_CR11","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.3390\/nu5093367","volume":"5","author":"S Thilakarathna","year":"2013","unstructured":"Thilakarathna S, Rupasinghe H. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients. 2013;5(9):3367\u201387.","journal-title":"Nutrients."},{"issue":"10","key":"674_CR12","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1021\/jf980117v","volume":"46","author":"MK Piskula","year":"1998","unstructured":"Piskula MK, Terao J. Quercetin\u2019s solubility affects its accumulation in rat plasma after oral administration. J Agric Food Chem. 1998;46(10):4313\u20137. \nhttps:\/\/doi.org\/10.1021\/jf980117v\n\n.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"674_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1389200214666131211160005","volume":"15","author":"L Biasutto","year":"2014","unstructured":"Biasutto L, Zoratti M. Prodrugs of quercetin and resveratrol: a strategy under development. Curr Drug Metab. 2014;15(1):77\u201395.","journal-title":"Curr Drug Metab"},{"issue":"2","key":"674_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3109\/21691401.2014.975238","volume":"44","author":"R Jangde","year":"2016","unstructured":"Jangde R, Singh D. Preparation and optimization of quercetin-loaded liposomes for wound healing, using response surface methodology. Artif Cells Nanomed Biotechnol. 2016;44(2):635\u201341. \nhttps:\/\/doi.org\/10.3109\/21691401.2014.975238\n\n.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"5","key":"674_CR15","doi-asserted-by":"publisher","first-page":"e0155710","DOI":"10.1371\/journal.pone.0155710","volume":"11","author":"C Saha","year":"2016","unstructured":"Saha C, Kaushik A, Das A, Pal S, Majumder D. Anthracycline drugs on modified surface of quercetin-loaded polymer nanoparticles: a dual drug delivery model for cancer treatment. PLoS One. 2016;11(5):e0155710. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0155710\n\n.","journal-title":"PLoS One"},{"issue":"1","key":"674_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejpb.2011.08.006","volume":"80","author":"M Kakran","year":"2012","unstructured":"Kakran M, Shegokar R, Sahoo NG, Shaal LA, Li L, Muller RH. Fabrication of quercetin nanocrystals: comparison of different methods. Eur J Pharm Biopharm. 2012;80(1):113\u201321. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2011.08.006\n\n.","journal-title":"Eur J Pharm Biopharm"},{"issue":"20","key":"674_CR17","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1039\/c5dt00817d","volume":"44","author":"BS Mendiguchia","year":"2015","unstructured":"Mendiguchia BS, Aiello I, Crispini A. Zn(II) and Cu(II) complexes containing bioactive O,O-chelated ligands: homoleptic and heteroleptic metal-based biomolecules. Dalton Trans. 2015;44(20):9321\u201334. \nhttps:\/\/doi.org\/10.1039\/c5dt00817d\n\n.","journal-title":"Dalton Trans"},{"issue":"8","key":"674_CR18","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1248\/cpb.26.2291","volume":"26","author":"K Takamura","year":"1978","unstructured":"Takamura K, Sakamoto M. Spectrophotometric studies on flavonoid-copper (II) complexes in methanol solution. Chem Pharm Bull. 1978;26(8):2291\u20137.","journal-title":"Chem Pharm Bull"},{"issue":"3","key":"674_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/10715760500484351","volume":"40","author":"H El Hajji","year":"2006","unstructured":"El Hajji H, Nkhili E, Tomao V, Dangles O. Interactions of quercetin with iron and copper ions: complexation and autoxidation. Free Radic Res. 2006;40(3):303\u201320. \nhttps:\/\/doi.org\/10.1080\/10715760500484351\n\n.","journal-title":"Free Radic Res"},{"issue":"1","key":"674_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0167-4889(87)90047-4","volume":"931","author":"JT Derksen","year":"1987","unstructured":"Derksen JT, Morselt HW, Scherphof GL. Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim Biophys Acta. 1987;931(1):33\u201340. \nhttps:\/\/doi.org\/10.1016\/0167-4889(87)90047-4\n\n.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"674_CR21","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","volume":"12","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni JA, Darjuan MM, Mercer JE, Chen S, van der Meel R, Thewalt JL, et al. On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA. ACS Nano. 2018;12(5):4787\u201395. \nhttps:\/\/doi.org\/10.1021\/acsnano.8b01516\n\n.","journal-title":"ACS Nano"},{"issue":"19","key":"674_CR22","doi-asserted-by":"publisher","first-page":"17161","DOI":"10.18632\/oncotarget.3635","volume":"6","author":"AW Leung","year":"2015","unstructured":"Leung AW, Dragowska WH, Ricaurte D, Kwok B, Mathew V, Roosendaal J, et al. 3\u2032-Phosphoadenosine 5\u2032-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents. Oncotarget. 2015;6(19):17161\u201377.","journal-title":"Oncotarget."},{"key":"674_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1061186X.2016.1186169","volume":"24","author":"M Wehbe","year":"2016","unstructured":"Wehbe M, Chernov L, Chen K, Bally MB. PRCosomes: pretty reactive complexes formed in liposomes. J Drug Target. 2016;24:1\u201326. \nhttps:\/\/doi.org\/10.1080\/1061186X.2016.1186169\n\n.","journal-title":"J Drug Target"},{"issue":"10","key":"674_CR24","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1158\/1078-0432.CCR-05-2365","volume":"12","author":"ZP Yuan","year":"2006","unstructured":"Yuan ZP, Chen LJ, Fan LY, Tang MH, Yang GL, Yang HS, et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res. 2006;12(10):3193\u20139. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-05-2365\n\n.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"674_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1517\/17425247.2012.679926","volume":"9","author":"W Gang","year":"2012","unstructured":"Gang W, Jie WJ, Ping ZL, Ming DS, Ying LJ, Lei W, et al. Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo. Expert Opin Drug Deliv. 2012;9(6):599\u2013613.","journal-title":"Expert Opin Drug Deliv"},{"key":"674_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jnutbio.2017.09.011","volume":"51","author":"C-S Lei","year":"2018","unstructured":"Lei C-S, Hou Y-C, Pai M-H, Lin M-T, Yeh S-L. Effects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: in vitro and in vivo studies. J Nutr Biochem. 2018;51:105\u201313. \nhttps:\/\/doi.org\/10.1016\/j.jnutbio.2017.09.011\n\n.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"674_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1742-7843.2011.00735.x","volume":"109","author":"AH Kne\u017eevi\u0107","year":"2011","unstructured":"Kne\u017eevi\u0107 AH, \u0110iki\u0107 D, Lisi\u010di\u0107 D, Kopjar N, Or\u0161oli\u0107 N, Karabeg S, et al. Synergistic effects of irinotecan and flavonoids on ehrlich ascites tumour-bearing mice. Basic Clin Pharmacol Toxicol. 2011;109(5):343\u20139. \nhttps:\/\/doi.org\/10.1111\/j.1742-7843.2011.00735.x\n\n.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7","key":"674_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.lfs.2008.06.007","volume":"83","author":"T Bansal","year":"2008","unstructured":"Bansal T, Awasthi A, Jaggi M, Khar RK, Talegaonkar S. Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein. Life Sci. 2008;83(7):250\u20139. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2008.06.007\n\n.","journal-title":"Life Sci"},{"issue":"4","key":"674_CR29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1158\/1078-0432.ccr-07-0780","volume":"14","author":"EC Ramsay","year":"2008","unstructured":"Ramsay EC, Anantha M, Zastre J, Meijs M, Zonderhuis J, Strutt D, et al. Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors. Clin Cancer Res. 2008;14(4):1208\u201317. \nhttps:\/\/doi.org\/10.1158\/1078-0432.ccr-07-0780\n\n.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"674_CR30","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10637-014-0138-x","volume":"32","author":"DN Waterhouse","year":"2014","unstructured":"Waterhouse DN, Sutherland BW, Santos ND, Masin D, Osooly M, Strutt D, et al. Irinophore C\u2122, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities. Investig New Drugs. 2014;32(6):1071\u201382. \nhttps:\/\/doi.org\/10.1007\/s10637-014-0138-x\n\n.","journal-title":"Investig New Drugs"},{"issue":"5","key":"674_CR31","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1021\/mp200209j","volume":"8","author":"AJ Smith","year":"2011","unstructured":"Smith AJ, Kavuru P, Wojtas L, Zaworotko MJ, Shytle RD. Cocrystals of quercetin with improved solubility and oral bioavailability. Mol Pharm. 2011;8(5):1867\u201376. \nhttps:\/\/doi.org\/10.1021\/mp200209j\n\n.","journal-title":"Mol Pharm"},{"issue":"2\u20133","key":"674_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00614022","volume":"9","author":"R Gugler","year":"1975","unstructured":"Gugler R, Leschik M, Dengler H. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol. 1975;9(2\u20133):229\u201334.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"674_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10517-009-0633-9","volume":"148","author":"TV Romanouskaya","year":"2009","unstructured":"Romanouskaya TV, Grinev VV. Cytotoxic effect of flavonoids on leukemia cells and normal cells of human blood. Bull Exp Biol Med. 2009;148(1):57\u20139.","journal-title":"Bull Exp Biol Med"},{"key":"674_CR34","doi-asserted-by":"publisher","first-page":"24049","DOI":"10.1038\/srep24049","volume":"6","author":"S Srivastava","year":"2016","unstructured":"Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, et al. Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep. 2016;6:24049. \nhttps:\/\/doi.org\/10.1038\/srep24049\n\n.","journal-title":"Sci Rep"},{"issue":"1","key":"674_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2008.11.006","volume":"34","author":"JL Hanslick","year":"2009","unstructured":"Hanslick JL, Lau K, Noguchi KK, Olney JW, Zorumski CF, Mennerick S, et al. Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system. Neurobiol Dis. 2009;34(1):1\u201310.","journal-title":"Neurobiol Dis"},{"key":"674_CR36","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.2147\/Ijn.S78983","volume":"10","author":"LW Chang","year":"2015","unstructured":"Chang LW, Hou ML, Hung SH, Lin LC, Tsai TH. Pharmacokinetics of quercetin-loaded nanodroplets with ultrasound activation and their use for bioimaging. Int J Nanomedicine. 2015;10:3031\u201342. \nhttps:\/\/doi.org\/10.2147\/Ijn.S78983\n\n.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"674_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0169-409X(89)90024-0","volume":"3","author":"PR Cullis","year":"1989","unstructured":"Cullis PR, Mayer LD, Bally MB, Madden TD, Hope MJ. Generating and loading of liposomal systems for drug-delivery applications. Adv Drug Deliv Rev. 1989;3(3):267\u201382. \nhttps:\/\/doi.org\/10.1016\/0169-409X(89)90024-0\n\n.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"674_CR38","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1039\/c6cc08607a","volume":"53","author":"N Bertleff-Zieschang","year":"2017","unstructured":"Bertleff-Zieschang N, Rahim MA, Ju Y, Braunger JA, Suma T, Dai Y, et al. Biofunctional metal-phenolic films from dietary flavonoids. Chem Commun (Camb). 2017;53(6):1068\u201371. \nhttps:\/\/doi.org\/10.1039\/c6cc08607a\n\n.","journal-title":"Chem Commun (Camb)"},{"issue":"5","key":"674_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3109\/10611869408996815","volume":"2","author":"MC Woodle","year":"1994","unstructured":"Woodle MC, Newman MS, Cohen JA. Sterically stabilized liposomes: physical and biological properties. J Drug Target. 1994;2(5):397\u2013403. \nhttps:\/\/doi.org\/10.3109\/10611869408996815\n\n.","journal-title":"J Drug Target"},{"issue":"2","key":"674_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.2042-7158.1998.tb06183.x","volume":"50","author":"DW Boulton","year":"1998","unstructured":"Boulton DW, Walle UK, Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J Pharm Pharmacol. 1998;50(2):243\u20139. \nhttps:\/\/doi.org\/10.1111\/j.2042-7158.1998.tb06183.x\n\n.","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"674_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/bdd.605","volume":"29","author":"YJ Moon","year":"2008","unstructured":"Moon YJ, Wang L, DiCenzo R, Morris ME. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos. 2008;29(4):205\u201317. \nhttps:\/\/doi.org\/10.1002\/bdd.605\n\n.","journal-title":"Biopharm Drug Dispos"},{"issue":"33","key":"674_CR42","doi-asserted-by":"publisher","first-page":"10758","DOI":"10.1039\/C7DT01955F","volume":"46","author":"M Wehbe","year":"2017","unstructured":"Wehbe M, Leung AWY, Abrams MJ, Orvig C, Bally MB. A perspective \u2013 can copper complexes be developed as a novel class of therapeutics? Dalton Trans. 2017;46(33):10758\u201373. \nhttps:\/\/doi.org\/10.1039\/C7DT01955F\n\n.","journal-title":"Dalton Trans"},{"issue":"9","key":"674_CR43","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1023\/a:1012259625746","volume":"12","author":"MJ Piccart","year":"2001","unstructured":"Piccart MJ, Lamb H, Vermorken JB. Current and future potential roles of the platinum drugs in the treatment of ovarian cancer. Ann Oncol. 2001;12(9):1195\u2013203. \nhttps:\/\/doi.org\/10.1023\/a:1012259625746\n\n.","journal-title":"Ann Oncol"},{"issue":"4","key":"674_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/med.20174","volume":"30","author":"F Tisato","year":"2010","unstructured":"Tisato F, Marzano C, Porchia M, Pellei M, Santini C. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev. 2010;30(4):708\u201349. \nhttps:\/\/doi.org\/10.1002\/med.20174\n\n.","journal-title":"Med Res Rev"},{"issue":"7","key":"674_CR45","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bbamcr.2006.05.001","volume":"1763","author":"K Balamurugan","year":"2006","unstructured":"Balamurugan K, Schaffner W. Copper homeostasis in eukaryotes: teetering on a tightrope. Biochim Biophys Acta, Mol Cell Res. 2006;1763(7):737\u201346. \nhttps:\/\/doi.org\/10.1016\/j.bbamcr.2006.05.001\n\n.","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"issue":"5","key":"674_CR46","doi-asserted-by":"publisher","first-page":"965S","DOI":"10.1093\/ajcn\/67.5.965S","volume":"67","author":"MC Linder","year":"1998","unstructured":"Linder MC, Wooten L, Cerveza P, Cotton S, Shulze R, Lomeli N. Copper transport. Am J Clin Nutr. 1998;67(5):965S\u201371S. \nhttps:\/\/doi.org\/10.1093\/ajcn\/67.5.965S\n\n.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"674_CR47","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/bjc.2012.442","volume":"107","author":"P Liu","year":"2012","unstructured":"Liu P, Brown S, Goktug T, Channathodiyil P, Kannappan V, Hugnot JP, et al. Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. Br J Cancer. 2012;107(9):1488\u201397. \nhttps:\/\/doi.org\/10.1038\/bjc.2012.442\n\n.","journal-title":"Br J Cancer"},{"issue":"6","key":"674_CR48","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1039\/c5tx00210a","volume":"4","author":"PE Tawari","year":"2015","unstructured":"Tawari PE, Wang Z, Najlah M, Tsang CW, Kannappan V, Liu P, et al. The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells. Toxicol Res. 2015;4(6):1439\u201342. \nhttps:\/\/doi.org\/10.1039\/c5tx00210a\n\n.","journal-title":"Toxicol Res"},{"key":"674_CR49","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.molstruc.2004.11.081","volume":"744\u2013747","author":"A Torreggiani","year":"2005","unstructured":"Torreggiani A, Tamba M, Trinchero A, Bonora S. Copper(II)\u2013quercetin complexes in aqueous solutions: spectroscopic and kinetic properties. J Mol Struct. 2005;744\u2013747:759\u201366. \nhttps:\/\/doi.org\/10.1016\/j.molstruc.2004.11.081\n\n.","journal-title":"J Mol Struct"},{"issue":"1\u20132","key":"674_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1023\/A:1007152927167","volume":"26","author":"J Zhou","year":"2001","unstructured":"Zhou J, Wang L, Wang J, Tang N. Antioxidative and anti-tumour activities of solid quercetin metal(II) complexes. Transit Met Chem. 2001;26(1\u20132):57\u201363. \nhttps:\/\/doi.org\/10.1023\/A:1007152927167\n\n.","journal-title":"Transit Met Chem"},{"issue":"1","key":"674_CR51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1021\/ja01606a076","volume":"77","author":"RL Pecsok","year":"1955","unstructured":"Pecsok RL, Juvet RS. The gluconate complexes. I. Copper gluconate complexes in strongly basic media1. J Am Chem Soc. 1955;77(1):202\u20136. \nhttps:\/\/doi.org\/10.1021\/ja01606a076\n\n.","journal-title":"J Am Chem Soc"},{"issue":"3","key":"674_CR52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0006-291X(75)80433-5","volume":"63","author":"RL Juliano","year":"1975","unstructured":"Juliano RL, Stamp D. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem Biophys Res Commun. 1975;63(3):651\u20138. \nhttps:\/\/doi.org\/10.1016\/S0006-291X(75)80433-5\n\n.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"674_CR53","first-page":"659","volume":"2","author":"DR Ferry","year":"1996","unstructured":"Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996;2(4):659\u201368.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"674_CR54","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0145-2126(02)00265-5","volume":"27","author":"JL Liesveld","year":"2003","unstructured":"Liesveld JL, Abboud CN, Lu C, McNair C, Menon A, Smith A, et al. Flavonoid effects on normal and leukemic cells. Leuk Res. 2003;27(6):517\u201327.","journal-title":"Leuk Res"},{"issue":"23","key":"674_CR55","first-page":"6676","volume":"52","author":"M Yoshida","year":"1992","unstructured":"Yoshida M, Yamamoto M, Nikaido T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res. 1992;52(23):6676\u201381.","journal-title":"Cancer Res"},{"issue":"5","key":"674_CR56","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0145-2126(92)90176-8","volume":"16","author":"L Teofili","year":"1992","unstructured":"Teofili L, Pierelli L, Iovino MS, Leone G, Scambia G, De Vincenzo R, et al. The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leuk Res. 1992;16(5):497\u2013503.","journal-title":"Leuk Res"},{"issue":"5","key":"674_CR57","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00280-011-1596-x","volume":"68","author":"D Staedler","year":"2011","unstructured":"Staedler D, Idrizi E, Kenzaoui BH, Juillerat-Jeanneret L. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother Pharmacol. 2011;68(5):1161\u201372. \nhttps:\/\/doi.org\/10.1007\/s00280-011-1596-x\n\n.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"674_CR58","first-page":"1153","volume":"16","author":"K Kelly","year":"2002","unstructured":"Kelly K. Current role of irinotecan in the treatment of non-small-cell lung cancer. Oncology (Williston Park). 2002;16(9):1153\u201362 65; discussion 65\u20136 passim.","journal-title":"Oncology (Williston Park)"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-019-00674-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:18:24Z","timestamp":1599002304000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-019-00674-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["674"],"URL":"https:\/\/doi.org\/10.1007\/s13346-019-00674-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"3 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All studies were conducted in accordance with the guidelines set by the Canadian Council on Animal Care, as overseen by the University of British Columbia\u2019s Animal Care Committee (protocols A10-0171, A10-0206, and A14-0290).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}